Lipid-lowering drugs and circulating adiponectin.

@article{Wanders2012LipidloweringDA,
  title={Lipid-lowering drugs and circulating adiponectin.},
  author={Desiree Wanders and Eric P Plaisance and Robert L. Judd},
  journal={Vitamins and hormones},
  year={2012},
  volume={90},
  pages={341-74}
}
Pharmacological agents used to treat primary and combined hyperlipidemia reduce cardiovascular disease morbidity and mortality. Risk reduction has been attributed to improvements in blood lipid and lipoprotein characteristics. However, each class of available lipid-lowering drugs has been shown to exhibit pleiotropic effects that broaden their anticipated… CONTINUE READING